BRPI0411324A - composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes - Google Patents
composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientesInfo
- Publication number
- BRPI0411324A BRPI0411324A BRPI0411324-1A BRPI0411324A BRPI0411324A BR PI0411324 A BRPI0411324 A BR PI0411324A BR PI0411324 A BRPI0411324 A BR PI0411324A BR PI0411324 A BRPI0411324 A BR PI0411324A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- pharmaceutical compositions
- patients
- mediated response
- treating histamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSIçõES FARMACêUTICAS E MéTODOS DE TRATAMENTO DE RESPOSTA MEDIADA POR HISTAMINA EM PACIENTES". A presente invenção proporciona composições farmacêuticas que incluem uma anti-histamina sedativa e um estimulante e métodos de uso das mesmas. O estimulante reduz a sedação causada pela antihistamina, permitindo, dessa maneira, que anti-histaminas potentes, mas, sedativas sejam usadas com efetividade.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/463,556 US20040259809A1 (en) | 2003-06-17 | 2003-06-17 | Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof |
PCT/US2004/018986 WO2004112771A1 (en) | 2003-06-17 | 2004-06-16 | Pharmaceutical compositions including an antihistamine and a stimulant and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0411324A true BRPI0411324A (pt) | 2006-07-25 |
Family
ID=33517116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0411324-1A BRPI0411324A (pt) | 2003-06-17 | 2004-06-16 | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040259809A1 (pt) |
EP (1) | EP1641446A1 (pt) |
JP (1) | JP2007527860A (pt) |
AU (1) | AU2004249186A1 (pt) |
BR (1) | BRPI0411324A (pt) |
CA (1) | CA2528711A1 (pt) |
MX (1) | MXPA05013758A (pt) |
WO (1) | WO2004112771A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8012506B2 (en) * | 2001-04-10 | 2011-09-06 | Pernix Therapeutics, Llc | Tannate compositions, methods of making and methods of use |
US8257746B2 (en) | 2001-04-10 | 2012-09-04 | Pernix Therapeutics, Llc | Tannate compositions, methods of making and methods of use |
US20070003622A1 (en) * | 2004-12-16 | 2007-01-04 | Sovereign Pharmaceuticals, Ltd. | Diphenhydramine containing dosage form |
US9592197B2 (en) | 2004-12-16 | 2017-03-14 | Sovereign Pharmaceuticals, Llc | Dosage form containing diphenhydramine and another drug |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
LT2486942T (lt) | 2004-11-24 | 2019-01-25 | Meda Pharmaceuticals Inc. | Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai |
US7529255B2 (en) * | 2005-04-21 | 2009-05-05 | Microsoft Corporation | Peer-to-peer multicasting using multiple transport protocols |
KR101495146B1 (ko) | 2006-03-16 | 2015-02-24 | 트리스 파마 인코포레이티드 | 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제 |
US20090325999A1 (en) * | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
EP2420147B1 (en) * | 2010-08-17 | 2017-05-17 | Vitae Natural Nutrition, S.L. | Nutritional supplement compositon |
WO2012090218A1 (en) | 2010-12-30 | 2012-07-05 | Zota Health Care Ltd | Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases |
US9149474B2 (en) * | 2011-11-23 | 2015-10-06 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
US9629847B2 (en) | 2011-11-23 | 2017-04-25 | Michael Leighton | Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant |
US20140100249A1 (en) * | 2012-10-09 | 2014-04-10 | Douglas Sears | Therapeutic Treatment |
CN104189011A (zh) * | 2014-09-29 | 2014-12-10 | 安徽安科恒益药业有限公司 | 一种小儿氨酚黄那敏颗粒的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1146183A (en) * | 1965-07-01 | 1969-03-19 | Stabilimenti Chimico Farmaceut | Improvements in or relating to nicotinamide derivatives having an analgesic, anti-inflammatory, antipyretic and anti-histaminic action, method for their preparation, andtherapeutical use |
NL6808619A (pt) * | 1968-06-19 | 1969-12-23 | ||
US3940485A (en) * | 1973-12-12 | 1976-02-24 | Levinson Harold N | Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds |
US4466960A (en) * | 1983-10-18 | 1984-08-21 | Thompson Medical Co., Inc. | Analgesic-diuretic compositions |
AU2100795A (en) * | 1994-06-06 | 1996-01-04 | Warner-Lambert Company | Non-sedating allergy sinus medication |
US5840731A (en) * | 1995-08-02 | 1998-11-24 | Virginia Commonwealth University | Pain-alleviating drug composition and method for alleviating pain |
US5648358A (en) * | 1996-03-05 | 1997-07-15 | Mitra; Sekhar | Compositions and methods for treating respiratory disorders |
AU5478699A (en) * | 1998-08-13 | 2000-03-06 | Bridge Pharma, Inc. | Non-sedating diphenhydramine metabolites |
-
2003
- 2003-06-17 US US10/463,556 patent/US20040259809A1/en not_active Abandoned
-
2004
- 2004-06-16 BR BRPI0411324-1A patent/BRPI0411324A/pt not_active Application Discontinuation
- 2004-06-16 EP EP04755265A patent/EP1641446A1/en not_active Withdrawn
- 2004-06-16 WO PCT/US2004/018986 patent/WO2004112771A1/en active Search and Examination
- 2004-06-16 MX MXPA05013758A patent/MXPA05013758A/es unknown
- 2004-06-16 JP JP2006517274A patent/JP2007527860A/ja active Pending
- 2004-06-16 AU AU2004249186A patent/AU2004249186A1/en not_active Abandoned
- 2004-06-16 CA CA002528711A patent/CA2528711A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007527860A (ja) | 2007-10-04 |
WO2004112771A1 (en) | 2004-12-29 |
AU2004249186A1 (en) | 2004-12-29 |
EP1641446A1 (en) | 2006-04-05 |
US20040259809A1 (en) | 2004-12-23 |
CA2528711A1 (en) | 2004-12-29 |
MXPA05013758A (es) | 2006-03-13 |
WO2004112771A8 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
CY1111458T1 (el) | Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης | |
NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
DE60314603D1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
CY1105080T1 (el) | Ενωσεις θειενοπυρρολυλιου και φουρανοπυρρολυλιου και η χρηση τους ως συνδετες η4 υποδοχεα ισταμινης | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
ATE451376T1 (de) | Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen | |
BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
NO20034549L (no) | Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV | |
UY27755A1 (es) | Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores. | |
PA8603201A1 (es) | Procedimiento y composiciones farmaceuticas para el tratamiento de arterosclerosis, dislipidemias y afecciones relacionadas | |
WO2004019884A3 (en) | Agents and methods for enhancing bone formation | |
CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
BRPI0409523A (pt) | método para o tratamento da dor neuropática, método de identificação de um composto e composição farmacêutica | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
ATE485037T1 (de) | Krebsbehandlung mittels fts und 2-deoxyglucose | |
NO20061236L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton | |
BRPI0406796A (pt) | Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina | |
BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
UY28007A1 (es) | Tratamiento terapeutico | |
CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |